Curcumin from the rhizome of Curcuma longa (zingiberaceae) has been reported to be a chemopreventive agent that affects cell proliferation by arresting the cell cycle in G2 and modulating the wnt signaling pathway. We found that curcumin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma (HCC) cells in a concentration-dependent manner. We identified that curcumin interrupts wnt signaling by decreasing β-catenin activity, which in turn suppresses the expression of β-catenin target genes (c-myc, VEGF and cyclin D1). Our results from molecular simulation of curcumin binding to Dvl2 protein and from binding free energy calculations suggest that curcumin may prevent axin recruitment to cellular membrane in order to maintain the functional β-catenin destruction complex in normal cells. This results in β-catenin being unable to accumulate in the nucleus, depriving the protein of its ability to bind with lymphoid enhancer factor/T cell-specific transcription factor (Lef/Tcf) and repressing its activation of target gene transcription. This may be one mechanism through which curcumin inhibits proliferation and induces apoptosis of HCC cells.
Introduction
Wnts are secreted cysteine-rich glycoproteins that convey signals from donor cells to adjacent recipient cells in a paracrine fashion (1) . Wnt homologues emerged from the simplest multicellular organisms, suggesting that wnt signaling pathway is one of the most fundamental signaling pathways in orchestrating cell-cell communication, tissue development and organogenesis (2) . The earliest studies in identifying wnt homologues and their functions were on C. elegans and Drosophila (3) . Two decades after these pioneering explorations, 19 structurally conserved wnt family members have been identified in humans (4) , from which the vastly complicated wnt regulation network was gradually established. Current knowledge shows that wnt signaling pathway plays important roles in embryonic development, postnatal tissue homeostasis and pathogenesis (5) .
The most studied wnt downstream signaling is through to be the β-catenin dependent pathway, referred to as wnt canonical signaling pathway (6, 7) . The core issue of the wnt canonical signaling pathway is the competition between elimination and accumulation of its major downstream mediator, β-catenin. Free β-catenin can be translocated and accumulated to the nucleus, where it binds to lymphoid enhancer factor/T cell-specific transcription factor (Lef/Tcf) in order to activate the transcription of target genes (8) . Although cells consistently synthesize β-catenin to maintain a potent responsiveness for incoming wnt signaling, the high turnover rate of β-catenin significantly limits β-catenin nuclear accumulation and the target gene expression (9) .
Many studies found that various types of cancer including colorectal, pancreatic, lung and prostate cancer, and leukemia are dependent on wnt aberrant signaling (10) (11) (12) . In fact, more than 80% colorectal cancers and 90% of renal cell carcinoma (RCC, the most frequent type of kidney cancer) are related to mutations in the wnt signaling pathway (13) (14) (15) (16) (17) . Hence, targeting the wnt signaling could be a promising strategy in treating these diseases (18) . However, systematic manipulation of wnt signaling may prove beneficial in treating certain diseases, it may cause damage to normal tissues that depend on the pathway (19, 20) .
Curcumin is a natural phenol extract from zingiberaceae. Preclinical studies suggest that curcumin has potential functions in preventing and treating many diseases, such as colon, gastric, intestinal and breast cancers, inflammatory diseases and HIV (21, 22) . It was reported that the chemo-preventive capability of curcumin was exactly through the modulation of the wnt canonical signaling pathway (23 The purpose of this study was to gain insight into the molecular mechanism of curcumin involved in the effects of wnt/β-catenin signaling pathway. Docking simulations in silico, binding free energy calculations, MTT assay, FACS-based apoptosis assay, immunoblot and RT-PCR were among the techniques used to validate our findings.
Materials and methods
Molecular docking between curcumin and Dvl2-PDZ domain. The molecular 3-D structure of Dvl2-PDZ domain was extracted from the Protein Data Bank (www.pdb.org, PDB CODE: 3CBY). The chemical structure of curcumin was constructed and optimized in the implicit solvent as preparation for docking, and the docking performance was executed employing the CDOCKER module on the platform of Discovery studio 2.5 (Accelrys Inc.). The critical peptide ligand binding site was defined as docking region (24) . The conformation search space was limited to a spherical region with the center of (37.6, 3.0, 7.3) and the radius of 9.5 Å. The other parameters were set according to the default values of the module, with all docking procedures using CHARMm forcefield, and a grid extension of 8.0. The ligand partial charge method was also used according to CHARMm. Ten top hits were obtained as docking results. Simulated annealing method was employed for the final conformation treatment: the system was heated to 700 K with 2,000 steps and then cooled to 300 K with 5,000 steps. Finally, the best conformation was selected as the object of analysis according to the values of score.
Binding free energy calculation. Binding free energy calculation was performed with MM-PBSA module of Amber12 (25) . In the MM-PBSA method, the free energy of the receptor/ligand binding, ΔG bind , is obtained from the difference between the free energies of the receptor/ ligand complex (∆G cpx ) and the unbound receptor (∆G rec ) and ligand (∆G lig ) as following:
The binding free energy (ΔG bind ) is evaluated as a sum of the changes of molecular mechanical (MM) gas-phase binding energy (ΔE MM ), solvation free energy (ΔG sol ) and entropic contribution (-TΔS): (v/v) fetal bovine serum, 1 x penicillin-streptomycin solution in a humidified 5% CO 2 atmosphere at 37˚C.
Cell proliferation assay. Cell proliferation was determined by MTT assay and used according to the manufacturer's instructions. Briefly, BEL-7402 and QGY-7703 cells were seeded into 96-well plates at a density of 5x10 3 per well (100 µl). After 24 h, the indicated concentrations of curcumin were added. After incubating for 48 h, cells were washed twice with PBS. MTT medium (10 µl) were then added into each well, at which time cells were incubated for another 4 h. After which, the medium was removed, and 150 µl of dissolution was added into each well. The plate was gently rotated on an orbital shaker for 10 min to dissolve the precipitation completely. The absorbances were detected at 492 nm with a Microplate reader.
Flow cytometry and apoptosis detection. BEL-7402 and QGY-7703 cells were treated with curcumin in complete medium for 48 h as previously described. Following the treatment, cells were harvested by trypsin (not containing EDTA) and rinsed twice with PBS at 4˚C. Cells were then resuspended in 1X Annexin V binding buffer. A total of 5 µl of Annexin V-FITC solution was added to each tube. All tubes were incubated for 15 min at 4˚C in darkness. PI solution (15 µl) was added to each tube. All tubes were incubated for another 5 min at 4˚C in darkness. Cells were then analyzed using flow cytometry (Accuri C6, USA).
Cell migration assay. BEL-7402 and QGY-7703 cells were cultured with curcumin at various concentrations on 6-well plates, and after 24 h the cells were scratched in straight line with tips. The scratched cells were washed off with PBS and the resting cells were cultured in fresh medium: cell migrations were measured at 6, 12 and 24 h, respectively, using ImageJ software.
Western blot analysis. To detect protein expression and modification in response to treatment with curcumin, HCC cells were plated onto 6-well plates at a density of 2x10 5 cells/ml and were then treated with various concentrations of curcumin. After incubating for 48 h, cells were lysed in cold RIPA lysis buffer. Total protein were extracted with high-salt buffer (0.5% sodium deoxycholate, 1% SDS, 1 mM sodium orthovanadate, 1 mM β-glycerol phosphate, 1 mM sodium fluoride, 2.5 mM sodium pyrophosphate) that contains a protease inhibitor cocktail (Roche, Nutley, NJ, USA). Protein samples were separated by SDS-PAGE, transferred onto PVDF membrane, and immunoblotted with the corresponding antibodies. The signal was visualized with Enhanced Chemiluminescence Plus (ECL Plus) detection system (Dingguo, China).
RT-PCR.
The BEL-7402 cells and QGY-7703 cells were treated with curcumin at 10, 20, 40 and 80 µM for 48 h as previously described. Total RNAs were extracted from the cells using a commercially available RNA-Bee isolation kit (Tel-Test). Standard reverse transcriptions were performed with 500 ng of total RNA using TIANScript RT kit (Tiangen, Beijing, China). RT-PCRs were performed by using 1 µl of cDNA template, 10 pmol of primers, and a PCR premix (1 unit of Taq DNA polymerase, 250 mM dNTPs, 10 mM Tris-HCl, 40 mM KCl and 1.5 mM MgCl 2 ; Tiangen). The following primers were used in the PCR reactions: c-myc forward, 5'-ctaccctctcaacgacagcag-3'; reverse, 5'gtgtgttcgcctcttgacatt-3'; VEGF forward, 5'-gcagaatca tcacgaagtggt-3'; reverse, 5'-catttgttgtgctgtaggaagc-3'; cyclin D1 forward, 5'-atctacaccgacaactccatcc-3'; reverse, 5'-gcattttggagag gaagtgttc-3'; β-actin forward, 5'-agagctacgagctgcctgctg-3'; reverse, 5'-agtacttgcgctcaggagga-3'.
The amplified products obtained from β-actin specific primers served as internal controls. PCRs were conducted using Bio-Rad T-100 (Bio-Rad, Hercules, CA, USA) with a denaturation step at 94˚C for 5 min; 30 cycles of 94˚C for 30 sec, 62˚C for 30 sec and 72˚C for 30 sec; and a final extension at 72˚C for 10 min. PCR amplifications were verified to be in the linear range.
Statistical analysis. Data were presented as mean ± SD for three separate experiments. One-way ANOVA was employed for statistical analysis using SPSS 17.0. P﹤0.05 was considered statistically significant.
Results

Molecular docking and binding free energy calculation
between curcumin and Dvl2-PDZ domain. The details of interaction between curcumin and dishevelled2 (Dvl2) PDZ domain is shown in Fig. 1A . According to the figure, the two separated hydrogen atoms of -NH 2 group of ARG338 formed hydrogen bonds with the C=O group in curcumin and 2 (-NH 2 ) groups of ARG338 with positive charge had cation-π interaction with an aromatic ring of curcumin. The backbone -NH groups of ILE282 and GLY284 formed hydrogen bonds with the C=O and OH in curcumin, respectively. The configuration of curcumin fits into a hydrophobic pocket of Dvl2-PDZ domain that is mainly constructed by LEU278, LGY279, ILE280, SER281, VAL283, PRO313, ASP331, VAL334, LEU337, VAL341 and HIS342 in a shape-shape complimentary pattern, as shown in Fig. 1B . To evaluate the binding free energy of curcumin with Dvl2-PDZ domain, 3 nsec MD simulation was performed for each complex. We also calculated binding free energy of Dvl2-PDZ with a well-known inhibitory N1 peptide, pep-N1 (WKDYGWIDG) (26) . Table I shows free energies of each items of protein in complex with curcumin and peptide based on the heavy atom RMSD of the last 2 nsec of each simulation. The RMSD values prove that the conformation of both complexes were stable.
Curcumin suppresses BEL-7402 and QGY-7703 cell proliferation and induces apoptosis.
To determine potential cytotoxic and anti-proliferative effects of curcumin, the human HCC cell lines BEL-7402 and QGY-7703 were cultured with curcumin at various concentrations (0-80 µM). Cell viability was then determined by MTT assay. Results showed that treatment with curcumin led to a significant dose-dependent inhibition of HCC cell growth in vitro ( Fig. 2A) . Curcumin suppressed BEL-7402 and QGY-7703 cell migration. The inhibitory effect of curcumin for HCC cell migration was confirmed by cell migration test. After 24 h, cells migrated to the scratch area, which achieved healing in control group without the curcumin treatment. When treated with curcumin, especially at 80 µM, cells grew and migrated at a much slower pace (Fig. 3A) . The width of the healewound was significantly different between groups treated with curcumin and the control group after 6 h, and the differences increased further after 12 and 24 h (Fig. 3B) .
Curcumin decreases β-catenin accumulation and downregulates expression of target genes in BEL-7402 and QGY-7703 cells.
After being treated with curcumin, expression of β-catenin in BEL-7402 and QGY-7703 cells decreased in a dose-dependent pattern as shown by western blot analysis. As a result, β-catenin activity in these cells was reduced in general (Fig. 4A) . Exposure to curcumin resulted in a dose-dependent decrease in the expression of cyclin D1 mRNA in both BEL-7402 and QGY-7703 cells, as demonstrated by RT-PCR experiments. Furthermore, the expressions of c-myc and VEGF was also significantly reduced at transcriptional level (Fig. 4B) . 
Discussion
In the absence of wnt ligands, newly synthesized β-catenin forms a complex in the cytosol with axin, adenomatous polyposis coli (APC), glycogen synthase kinase 3β (GSK3β) and casein kinase 1α (CK1α). In this complex, β-catenin is constitutively phosphorylated by CK1α and subsequently by GSK3β. The phosphorylated β-catenin is recognized by the ubiquitin ligase β-transducin-repeat containing protein (β-Trcp), targeted to the proteasome pathway and degraded by 26S proteasome (1) . Thus, free β-catenin is maintained at a low level in the cytoplasm, suppressing the expression of many target genes that are important for cell survival and proliferation. When the wnt ligand binds to wnt receptor, the ligand-receptor complex will recruit dishevell (Dvl) and axin from cytosol to the membrane. The binding of Dvl with axin Figure 5 . The mechanism of curcumin involved in the Wnt canonical signaling pathway. Wnt ligands bind to Frizzled receptor and LRP5/6 co-receptors, trigger the cell membrane recruitment of Dvl which in turn recruit axin, CK1α and GSK3β to the membrane, induce the accumulation of free β-catenin in the cytoplasm. The nuclear translocation of β-catenin will turn on the expression of target genes. When curcumin binds to Dvl, it will inhibit the recruitment of axin, CK1α and GSK3β to the membrane. Cucumin might also bind to Hsp90, dephosphorylate Akt and activate GSK3β to maintain the β-catenin destruction complex. Both bindings by curcumin will set the cell in Wnt 'off-state' suppressing the nucleus accumution of β-catenin and the expression of Wnt target genes.
then recruits CK1α and GSK3β to LRP5/6, which consequently inhibits the formation of the β-catenin destruction complex (27, 28) . As a result, the accumulated free β-catenin in cytoplasm is recruited to the nucleus by Bcl-9/legless (Bcl-9) adaptor protein and binds to the Tcf/Lef transcription factor, which in turn activates the expression of wnt target genes involved in cell proliferation and survival (29) .
To study the mechanism of curcumin inhibitory effects on carcinoma cells, molecular docking simulation was performed. The docking results suggest that curcumin has strong interactions with Dvl2-PDZ domain, which involves cation-π interaction, salt-bridge bond and multiple backbone interactions. We then calculated binding free energy between curcumin and Dvl2-PDZ domain. Based on negative total binding free energy -6.3386 kcal/mol, it was clearly seen that Dvl2-PDZ/curcumin is a favorable protein/ligand complex. Though the binding energy of curcumin is weaker than that of pep-N1 with the nine residues, the ΔG bind/heavy atom of curcumin is nearly equal to that of pep-N1. These results suggest that the interaction between curcumin and Dvl2-PDZ domain results in curcumin suppressing Dvl2 activities and subsequently preventing axin recruitment to cellular membrane, which eventually results in the phosphorylation of β-catenin through the destruction complex and digestion by the proteasome system.
We confirmed that curcumin significantly inhibited carcinoma cell growth in vitro in two human HCC cell lines, BEL-7402 and QGY-7703, shown in dose-dependent pattern using MTT assay. Additionally, curcumin interrupted Wnt signaling pathway and decreased β-catenin activity in a dosedependent manner, as shown by western blot analysis. HCC cells treated with curcumin resulted in significant transcriptional decrease of many genes related to cell growth, survival and apoptosis, including c-myc, VEGF and cyclin D1, by RT-PCR experiment. This in turn led to HCC cell apoptosis and prevented HCC cell migration, as demonstrated by apoptosis assay and cell migration assay, respectively.
Our data suggest that anti-proliferative function of curcumin results from curcumin inhibition of wnt/β-catenin signaling pathway as shown in the diagram (Fig. 5) . Based on our conclusion, the binding of curcumin to Dvl2 helps the formation of the β-catenin destruction complex, which turns the Wnt signaling pathway to 'off state' by decreasing free β-catenin levels in the cytoplasm. However, it was reported that curcumin can bind to Hsp90 proteins (30) . One group indicated that the Hsp90 inhibitor can dephosphorylate Akt and activate GSK3β (12) . Therefore, curcumin might regulate the β-catenin destruction complex in two different ways and attenuate the wnt signals in carcinoma cells, but there is still a long way to go before the mechanism of curcumin is fully understood so that it would be beneficial for the patients with HCC.
